These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20221587)

  • 1. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
    Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
    Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
    Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
    Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of sulfonamide detoxification pathways in haematologic malignancy patients prior to intermittent trimethoprim-sulfamethoxazole prophylaxis.
    Abouraya M; Sacco JC; Kahl BS; Trepanier LA
    Br J Clin Pharmacol; 2011 Apr; 71(4):566-74. PubMed ID: 21204907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
    Sacco JC; Trepanier LA
    Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC).
    Ott G; Plitzko B; Krischkowski C; Reichmann D; Bittner F; Mendel RR; Kunze T; Clement B; Havemeyer A
    Chem Res Toxicol; 2014 Oct; 27(10):1687-95. PubMed ID: 25170804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
    Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
    Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
    Wong YY; Rakasz EG; Gasper DJ; Friedrich TC; Trepanier LA
    Toxicology; 2016 Aug; 368-369():10-18. PubMed ID: 27565715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
    Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
    Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ascorbate deficiency is associated with impaired reduction of sulfamethoxazole-nitroso in HIV infection.
    Trepanier LA; Yoder AR; Bajad S; Beckwith MD; Bellehumeur JL; Graziano FM
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1041-50. PubMed ID: 15247557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells.
    Burkhart C; von Greyerz S; Depta JP; Naisbitt DJ; Britschgi M; Park KB; Pichler WJ
    Br J Pharmacol; 2001 Feb; 132(3):623-30. PubMed ID: 11159714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual oil fly ash inhalation in guinea pigs: influence of absorbate and glutathione depletion.
    Norwood J; Ledbetter AD; Doerfler DL; Hatch GE
    Toxicol Sci; 2001 May; 61(1):144-53. PubMed ID: 11294985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.
    Roychowdhury S; Vyas PM; Reilly TP; Gaspari AA; Svensson CK
    J Pharmacol Exp Ther; 2005 Jul; 314(1):43-52. PubMed ID: 15784651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation.
    Naisbitt DJ; Farrell J; Gordon SF; Maggs JL; Burkhart C; Pichler WJ; Pirmohamed M; Park BK
    Mol Pharmacol; 2002 Sep; 62(3):628-37. PubMed ID: 12181439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.
    Cribb AE; Spielberg SP; Griffin GP
    Drug Metab Dispos; 1995 Mar; 23(3):406-14. PubMed ID: 7628308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
    Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
    Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo.
    Cheng L; Stewart BJ; You Q; Petersen DR; Ware JA; Piccotti JR; Kawabata TT; Ju C
    Mol Pharmacol; 2008 Jun; 73(6):1769-75. PubMed ID: 18334600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and chemical origins of cross-reactive immunological reactions to arylamine benzenesulfonamides: T-cell responses to hydroxylamine and nitroso derivatives.
    Castrejon JL; Lavergne SN; El-Sheikh A; Farrell J; Maggs JL; Sabbani S; O'Neill PM; Park BK; Naisbitt DJ
    Chem Res Toxicol; 2010 Jan; 23(1):184-92. PubMed ID: 19954178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides.
    Elzagallaai AA; Sultan EA; Bend JR; Abuzgaia AM; Loubani E; Rieder MJ
    J Clin Pharmacol; 2020 Mar; 60(3):409-421. PubMed ID: 31709574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.